https://scholars.lib.ntu.edu.tw/handle/123456789/510264
標題: | Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer | 作者: | Cho S.-L. WEI-CHOU LIN Chuang C.-A. WEI-YU LIAO CHUN-FU LAI |
公開日期: | 2020 | 出版社: | Blackwell Publishing | 來源出版物: | Nephrology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085060665&doi=10.1111%2fnep.13721&partnerID=40&md5=c138d36dd4678b653e5d158a150a0744 https://scholars.lib.ntu.edu.tw/handle/123456789/510264 |
ISSN: | 1320-5358 | DOI: | 10.1111/nep.13721 | SDG/關鍵字: | creatinine; epidermal growth factor receptor; erlotinib; gefitinib; linagliptin; metformin; nifedipine; prednisolone; antineoplastic agent; erlotinib; glucocorticoid; prednisolone; aged; cancer staging; cancer therapy; case report; clinical article; creatinine blood level; diabetes mellitus; disease association; drug dose reduction; drug substitution; drug withdrawal; eczema; follow up; gene mutation; human; human tissue; hypertension; hypomagnesemia; immunohistochemistry; interstitial nephritis; kidney biopsy; kidney fibrosis; laboratory test; Letter; leukocyturia; lung adenocarcinoma; male; physical examination; priority journal; protein to creatinine ratio; treatment duration; treatment response; biopsy; convalescence; drug effect; interstitial nephritis; kidney; kidney function test; lung adenocarcinoma; lung tumor; pathology; pathophysiology; procedures; treatment withdrawal; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Biopsy; Erlotinib Hydrochloride; Glucocorticoids; Humans; Kidney; Kidney Function Tests; Lung Neoplasms; Male; Nephritis, Interstitial; Prednisolone; Recovery of Function; Withholding Treatment |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。